Wednesday, June 30, 2021 11:31:29 AM
My understanding is we can't use the 48.6 because that's SEER data, and we're talking about what actually happened between the test and control arms, etc.,
Maybe it can come out in a scientific paper why the entire population of the study did so well.
Maybe it could say something like "keytruda" was later applied to just about everyone also. That sort of thing. There is no way to know until the papers come out.
The study protocol does not preclude ANY further treatment by ANY means.
Clear ?
Before we got any data whatsoever, the ONLY thing in the world to compare the trail run length to was SEER data.
The actual race is between test and control groups
Maybe it can come out in a scientific paper why the entire population of the study did so well.
Maybe it could say something like "keytruda" was later applied to just about everyone also. That sort of thing. There is no way to know until the papers come out.
The study protocol does not preclude ANY further treatment by ANY means.
Clear ?
Before we got any data whatsoever, the ONLY thing in the world to compare the trail run length to was SEER data.
The actual race is between test and control groups
Recent CVM News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/04/2025 05:15:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:31:28 PM
- CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 • Newsfile • 10/20/2025 01:00:00 PM
- CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference • Newsfile • 10/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 08:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:57:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:46:01 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/29/2025 08:16:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 05:15:44 PM
- CEL-SCI Announces Closing of $10 Million Public Offering • Business Wire • 08/29/2025 04:52:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/28/2025 08:24:34 PM
